FSTL3 is a Prognostic Biomarker in Gastric Cancer and is Correlated with M2 Macrophage Infiltration

Abstract

Taken together, our findings suggest that <i>FSTL3</i> may be involved in GC progression via the promotion of BMP/SMAD signaling-mediated EMT and M2 macrophage activation.